siRNA targeted knockdown studies have shown that SFK member LCK plays a crucial role in mediating YAP Y357 phosphorylation and the YAP Y357 phosphorylation pathway in LCK-mediated CCA is a potential therapeutic target. This evidence concerns the gene LCK and cholangiocarcinoma.